KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Other Non Operating Income (2016 - 2026)

Chemed filings provide 17 years of Other Non Operating Income readings, the most recent being -$1000.0 for Q1 2026.

  • For the quarter ending Q1 2026, Other Non Operating Income changed 0.0% year-over-year to -$1000.0, compared with a TTM value of -$13000.0 through Mar 2026, down 107.56%, and an annual FY2025 reading of -$13000.0, down 533.33% over the prior year.
  • Other Non Operating Income hit -$1000.0 in Q1 2026 for Chemed, up from -$6000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $381000.0 in Q4 2022, with the low at -$8000.0 in Q2 2023.
  • Median Other Non Operating Income over the past 5 years was $0.0 (2022), compared with a mean of $43000.0.
  • The largest YoY upside for Other Non Operating Income was 6900.0% in 2023 against a maximum downside of 500.0% in 2023.
  • Year by year, Other Non Operating Income stood at $381000.0 in 2022, then tumbled by 55.12% to $171000.0 in 2023, then tumbled by 98.83% to $2000.0 in 2024, then tumbled by 400.0% to -$6000.0 in 2025, then surged by 83.33% to -$1000.0 in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$1000.0, -$6000.0, and -$7000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.